Clorox CO /DE/ Form 4 insider transactions

Clorox EVP and Chief Legal Officer Angela C. Hilt reported a disposition of 347 common shares to cover tax obligations related to previously granted restricted stock units.

Clorox Director Pierre R. Breber acquired 4,000 shares of common stock at a weighted average price of $104.1291 per share through a trust.

Clorox CEO Linda Rendle reported the settlement of 2022 performance unit grants, acquiring 43,370 shares, and subsequent tax-related dispositions of 9,462 shares, resulting in a beneficial ownership of 201,990 shares.

Clorox VP Laurene Peck reported the settlement and deferral of a 2022 performance unit grant, along with tax-related share disposals and updated beneficial ownership.

Clorox EVP Chris T. Hyder reported the deferral of 6,812 shares from a performance unit grant and tax-related dispositions, resulting in a net beneficial ownership of 35,133 shares.

Clorox EVP Stacey Grier reported the future settlement of a performance unit grant and subsequent tax-related share dispositions, deferring a significant portion.

Clorox's Chief Operating Officer, Eric H. Reynolds, acquired 15,489 shares through a performance unit grant settlement while simultaneously disposing of 10,191 shares for tax obligations.

Clorox EVP Kirsten Marriner reported the acquisition of shares from vested performance units and subsequent dispositions for tax obligations.

Clorox EVP and Chief Legal Officer Angela C. Hilt reported the vesting of performance units, subsequent tax-related share withholdings, and changes in her beneficial ownership of company common stock.

Clorox EVP and CFO Luc Bellet reported the vesting of performance units and subsequent tax-related stock withholdings on October 3, 2025.

Clorox Executive Vice President Nina Barton disposed of 622 shares of common stock on October 3, 2025, to satisfy tax obligations related to restricted stock vesting, while also acquiring 21 shares through dividend reinvestment.

Clorox Director Christopher J. Williams increased his beneficial ownership of the company's stock through the acquisition of deferred stock units via dividend reinvestment and director's fees.

Clorox Director Russell J. Weiner increased his beneficial ownership of the company's deferred stock units through dividend reinvestment and receipt of director's fees.

Clorox Director Matthew J. Shattock increased his beneficial ownership of Deferred Stock Units through routine dividend reinvestment and receipt of quarterly director's fees.

Clorox Director Stephanie Plaines increased her beneficial ownership of the company's stock through the acquisition of deferred stock units via dividend reinvestment and director fees.

Clorox Director Spencer C. Fleischer expanded his beneficial ownership by acquiring additional deferred stock units through dividend reinvestment and quarterly director fees.

Clorox Director Pierre R Breber reported changes in his beneficial ownership, including indirect common stock holdings and deferred stock units acquired through dividend reinvestment and director fees.

Clorox VP Laurene Peck acquired 1,441 shares of common stock through a restricted stock unit grant, scheduled for September 16, 2025, and vesting over four years.

Clorox EVP Stacey Grier acquired 3,364 shares of common stock through a Restricted Stock Unit grant, increasing her beneficial ownership to 23,190 shares.

Clorox's EVP and Chief Legal Officer, Angela C. Hilt, acquired 7,048 shares of common stock through a restricted stock unit grant on September 16, 2025.

Kirsten Marriner, EVP Chief Admin Officer of Clorox, acquired 7,689 shares of common stock at $124.85 per share.

Clorox EVP-Group President Chris T Hyder received a grant of 7,208 restricted stock units, vesting over four years.

Clorox EVP Nina Barton acquired 7,208 shares of common stock through Restricted Stock Units, vesting over four years, as part of a Rule 10b5-1 plan.

Clorox's EVP and Chief Operating Officer, Eric H. Reynolds, acquired 9,611 shares of common stock through a Restricted Stock Unit grant.

Clorox Company's EVP and Chief Financial Officer, Luc Bellet, acquired 7,368 shares of common stock at $124.85 per share, increasing his direct beneficial ownership to 19,546 shares.

Clorox CEO Linda J Rendle increased her beneficial ownership by 34,281 shares of common stock through a Restricted Stock Unit grant valued at approximately $4.28 million.

Clorox EVP and COO Eric H. Reynolds exercised stock options and subsequently sold a portion of his common stock holdings.

Clorox EVP Nina Barton reported a pre-planned disposition of 1,610 common shares at $126.57 per share, effective July 22, 2025, to cover tax obligations.

Clorox EVP Chris T. Hyder reported a disposition of 265 common shares to cover tax obligations related to restricted stock vesting, maintaining a significant beneficial ownership.

Clorox Co. Director Christopher J. Williams increased his beneficial ownership of the company's deferred stock units through dividend reinvestment and in lieu of quarterly director's fees, bringing his total holdings to 19,046.2446 units.